TSS
ASBPW

Two Sigma Securities’s Aspire Biopharma Warrant ASBPW Stock Holding History

Two Sigma Securities’s Portfolio ASBPW Stock Details ASBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$825 Buy
+41,269
New +$739 ﹤0.01% 1628

Other funds holding ASBPW

SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

Two Sigma Securities's ASBPW Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Aspire Biopharma Warrant (ASBPW) in Q2 2026: 41,269 shares worth $825. The stake represents ﹤0.01% of the portfolio and ranks #1628 among its holdings.

27 funds tracked by Wall St. Rank hold ASBPW as of Q2 2026.

  • Two Sigma Securities held 41,269 shares of Aspire Biopharma Warrant worth $825 as of Q2 2026.
  • Aspire Biopharma Warrant was a new Two Sigma Securities position in Q2 2026.
  • Aspire Biopharma Warrant made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1628 holding.
  • 27 funds tracked by Wall St. Rank held Aspire Biopharma Warrant as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.